Call For Proposals Technical Assistance On Development of The Philippine Medicines Policy 2020-2030

CALL FOR PROPOSALS
Technical Assistance on Development of the

Philippine Medicines Policy 2020-2030
1. Summary
The World Health Organization (WHO) Philippines is looking for an individual or

institution contractual partner for an Agreement for Performance of Work. The proposals are
due by 16 February 2020.
2. Background
In the 1980s, the worldwide concern on the problem of inadequate access to essential
medicines and its irrational use paved way for the declaration of the Philippine National Drug
Policy (PNDP), which aimed to make essential medicines available, accessible and
affordable to the people. This policy is anchored on four pillars that are interdependent and
mutually reinforcing: Quality assurance, Rational Drug Use, Self-reliance, and Tailored
procurement.
The PNDP was further improved through the development of the Philippine Medicines
Policy (PMP) in 2010, which set the strategic directions on access to medicines for Filipinos
for the medium term 2011 to 2016. The PMP 2011-2016 identified five (5) key components
called the SARAH Framework. SARAH corresponds to 1) Safety, Efficacy and Quality (SEQ)
of medicines, 2) Affordability and Availability, 3) Rational Drug Use,4) Accountability,
Transparency and Good Governance and 5) Health Systems Support. Through its
implementation along with key legislations, including Republic Act 9502 (Universally
Accessible Cheaper and Quality Medicines Act of 2008), Republic Act 6675 (Generics Act of
1988) and many others, much progress has been made in medicines access over the last
six (6) years. However, despite the many initiatives, much work is still left to be done to
improve medicines access to a level sufficient to meet the demands of Universal Health
Coverage.
In line with the passing of the Universal Health Care Law, the Philippine Medicines
Policy needs to be re-assessed to ensure improved and continuous access to essential
medicines in the country. The implementation framework to achieve UHC should be
anchored on financial risk protection, access to quality health care facilities, and attainment
of health-related Sustainable Development Goals, supported by adequate human resources
and systems support. The PMP should also be aligned to the WHO Access to Medicines and
Vaccines RoadMap 2019-2023 which outlines ten priority areas: (1) research and
development for medicines and vaccines that meets public health needs; (2) fair pricing and
financing policies; (3) application and management of intellectual property to contribute to
innovation and promote public health; (4) procurement and supply chain management; (5)
appropriate prescribing, dispensing and use; (6) regulatory systems that ensure quality,
safety and efficacy of medicines and vaccines; (7) preparedness for emergencies; (8) good
governance; (9) collecting, monitoring and using key data; and (10) health workforce
capacity for access to medicines and vaccines.
Overall Objective:
To propose strategic directions in improving access to medicines in the Philippines
for 2020-2030.
Specific Objectives:
• To conduct a rapid implementation review of the Philippine Medicines Policy (2011-
2016);
• To develop a DOH-FDA Joint Roadmap that shall streamline and harmonize the
efforts of both national agencies towards promoting access to medicines;
• To develop a Pharmaceutical Financing Framework that shall serve as a guide
towards achieving a sustainable pharmaceutical financing mechanism in the
Philippines; and
• To draft the Philippine Medicines Policy (2020-2030) aligned with the UHC Law and
WHO Draft Road Map for Access to Medicines, Vaccines and Other Health Products
2019-2023.
3. Timeline
The implementation timeline for the project is six (6) months from 24 February 2020 to
23 August 2020.
4. Place of Assignment
Manila, Philippines
5. Scope of Work
In coordination with the WHO Philippines and the Department of Health, the selected
contractual partner shall perform the following activities:
Method(s) to carry out the activity

• Form a team of qualified and competent individuals with defined roles and tasks aligned
with the objectives;
• Conduct an implementation review of the Philippine Medicines Policy (2011 -2016);
• Conduct alignment meetings with WHO and DOH with full documentation for progress
monitoring;
• Conduct consultative stakeholders meetings;
• Draft the Philippine Medicines Policy (2020-2030) to include a DOH-FDA Joint
Roadmap, policy framework on pharmaceutical financial sustainability, and monitoring
and evaluation tool;
• Draft an Administrative Order on the implementation of the Philippine Medicines Policy
(2020-2030) including documentary requirements/attachments, such as but not limited to
policy memo and documentation of consultation meetings pertinent to the same;
• Present the final output to WHO Philippines and the DOH; and
• Submit full reports with presentation slides, as appropriate, in electronic (Microsoft Office
or equivalent) and triplicate hard copies.
Output/s
Output 1: Inception Report and Gantt chart of activities
Deliverable 1.1: Develop a work plan with Gantt chart of activities. The work plan will
be part of the inception report that will be submitted to WHO Philippines at the beginning
of the engagement. The inception report will demonstrate the contractual partner’s
conceptual and implementation approach and methodology, scope of work, resources
required, and the timeline of activities to guide the assignment and to meet the agreed-
upon deliverables;
Deliverable 1.2: Discuss the inception report and work plan with WHO Philippines
and DOH;
Output/Deliverable 2: Implementation Review of Philippine Medicines Policy

(2011-2016)
Deliverable 2.1: Submit a full report on the implementation of Philippine Medicines

Policy (2011-2016);
Output 3: Philippine Medicines Policy (2020-2030)
Deliverable 3.1: Submit a clean draft of the Philippine Medicines Policy (2020-2030);
Deliverable 3.2: Submit a clean draft of an Administrative Order on the
implementation of the Philippine Medicines Policy (2020-2030); and
Output 4: Final Report

Deliverable 4.1: Submit accomplishment and financial reports.
NOTE: Every report should have the following disclaimer:

This document has been produced with the assistance of the World Health Organization.
The contents of this publication are the sole responsibility of the author, and does not
necessarily reflect the opinions, recommendations, or advice of the World Health
Organization.
CONFIDENTIALITY
The results, products and reports of this technical assistance are to be treated as
confidential and must not be handed over to third parties. WHO and the Philippine DOH
have the exclusive ownership of the reports and reserve the right to further disseminate
relevant information.
6. Qualifications
The contractual partner must fulfill the following qualifications:
Education and Certifications

• At least a post-graduate degree holder in public health, health policy, law or a related
course; and
• Established and reputable work on public health policy.
Work Experience
• Relevant experience of at least 5 years related to policy development, review and
implementation; and
• Working with various stakeholders including the private sector, civic societies,
government and international development organizations.
Skills and Knowledge

• Solid background on medicines policy, public health law, and Philippine health
system;
• Policy development and implementation review; and
• Organizational, communication, interpersonal and analytical skills.
Language Fluency:
• Expert fluency in written and spoken English (essential) and Filipino (desired)
In addition, the contractual partner must have no direct or indirect interest in the tobacco
industry, alcohol industry, arms dealing or human trafficking.
7. Other Requirements
May require minimal travel within Metro Manila, Philippines
8. Submission Requirements
Interested institutions and/or individuals should submit electronic copies of the following:
• Cover letter
• Proposal with financial details and timelines
• Company profile and qualifications of team members (if institution) or curriculum vitae
(if individual)
Address all proposals to:

Dr Rabindra Abeyasinghe
Acting, WHO Representative in the Philippines
Ground Floor, Building 3, Department of Health San Lazaro Compound
Rizal Avenue, Sta Cruz, Manila
Please submit the electronic copy of the proposals with the title, Technical Assistance on
Development of the Philippine Medicines Policy 2020-2030 to Mrs. Ying Chen
[email protected] and [email protected]. Only shortlisted applicants will be contacted by
WHO Philippines.
Deadline of submission of proposals is on 16 February 2020.

Call For Proposals Technical Assistance On Development of The Philippine Medicines Policy 2020-2030

Uploaded by

Copyright:

Available Formats

Call For Proposals Technical Assistance On Development of The Philippine Medicines Policy 2020-2030

Uploaded by

Document Information

Original Description:

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Call For Proposals Technical Assistance On Development of The Philippine Medicines Policy 2020-2030

Uploaded by

Copyright:

Available Formats

CALL FOR PROPOSALS

Technical Assistance on Development of the

The World Health Organization (WHO) Philippines is looking for an individual or

Method(s) to carry out the activity

Output/Deliverable 2: Implementation Review of Philippine Medicines Policy

Deliverable 2.1: Submit a full report on the implementation of Philippine Medicines

Output 3: Philippine Medicines Policy (2020-2030)

Output 4: Final Report

NOTE: Every report should have the following disclaimer:

Education and Certifications

Skills and Knowledge

Address all proposals to:

Deadline of submission of proposals is on 16 February 2020.

You might also like